Login to BlackFacts.com using your favorite Social Media Login. Click the appropriate button below and you will be redirected to your Social Media Website for confirmation and then back to Blackfacts.com once successful.
Enter the email address and password you used to join BlackFacts.com. If you cannot remember your login information, click the “Forgot Password” link to reset your password.
Swiss drug maker Roche Group (RHHBY) and its U.S. unit Genentech announced Wednesday the initiation of an innovative Phase III clinical trial program for investigational medicine fenebrutinib in multiple sclerosis or MS.
